PRQR: ProQR Therapeutics N.V
PRQR exchange rate has changed by 4.43% for today. During the day, the instrument was traded at a low of 1.60 and at a high of 1.74.
Follow ProQR Therapeutics N.V dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PRQR News
- ProQR stock falls after initial AX-0810 data, pipeline updates
- ProQR reports positive initial AX-0810 safety data in phase 1 trial
- ProQR Therapeutics N.V. (PRQR) Presents at TIDES Europe 2025 - Slideshow (NASDAQ:PRQR) 2025-11-18
- ProQR Therapeutics NV earnings beat, revenue fell short of estimates
- ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates
- ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2025-11-04
- ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript
- Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates
- ProQR Therapeutics stock rating reiterated at Market Outperform by Citizens
- ProQR receives EMA approval for Phase 1 trial of RNA editing therapy
- ProQR stock rating reiterated at Market Outperform by Citizens
- ProQR Therapeutics Stock: Not A Needle Mover Just Yet (NASDAQ:PRQR)
- ProQR Therapeutics NV earnings missed by €0.04, revenue fell short of estimates
- Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates
- ProQR stock rating reiterated by Cantor Fitzgerald ahead of key 2H25 data
- ProQR stock advances as Cantor Fitzgerald reaffirms $8 price target
- ProQR stock advances as JMP reiterates bullish stance on RNA editing
- ProQR submits clinical trial application for RNA editing therapy
- This Ralph Lauren Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Blaize Holdings (NASDAQ:BZAI), Maplebear (NASDAQ:CART)
Frequently Asked Questions
What is PRQR stock price today?
ProQR Therapeutics N.V stock is priced at 1.65 today. It trades within 1.60 - 1.74, yesterday's close was 1.58, and trading volume reached 750. The live price chart of PRQR shows these updates.
Does ProQR Therapeutics N.V stock pay dividends?
ProQR Therapeutics N.V is currently valued at 1.65. Dividend policy depends on the company, while investors also watch -20.67% and USD. View the chart live to track PRQR movements.
How to buy PRQR stock?
You can buy ProQR Therapeutics N.V shares at the current price of 1.65. Orders are usually placed near 1.65 or 1.95, while 750 and 3.12% show market activity. Follow PRQR updates on the live chart today.
How to invest into PRQR stock?
Investing in ProQR Therapeutics N.V involves considering the yearly range 1.07 - 3.10 and current price 1.65. Many compare -19.51% and -21.43% before placing orders at 1.65 or 1.95. Explore the PRQR price chart live with daily changes.
What are ProQR Therapeutics N.V stock highest prices?
The highest price of ProQR Therapeutics N.V in the past year was 3.10. Within 1.07 - 3.10, the stock fluctuated notably, and comparing with 1.58 helps spot resistance levels. Track ProQR Therapeutics N.V performance using the live chart.
What are ProQR Therapeutics N.V stock lowest prices?
The lowest price of ProQR Therapeutics N.V (PRQR) over the year was 1.07. Comparing it with the current 1.65 and 1.07 - 3.10 shows potential long-term entry points. Watch PRQR moves on the chart live for more details.
When did PRQR stock split?
ProQR Therapeutics N.V has gone through stock splits historically. These changes are visible in , 1.58, and -20.67% after corporate actions.
- Previous Close
- 1.58
- Open
- 1.60
- Bid
- 1.65
- Ask
- 1.95
- Low
- 1.60
- High
- 1.74
- Volume
- 750
- Daily Change
- 4.43%
- Month Change
- -19.51%
- 6 Months Change
- -21.43%
- Year Change
- -20.67%
- Act
- Fcst
- Prev